Over the past 12 months, 1 insider at Damora Therapeutics, Inc. filed 1 open-market SEC Form 4 transaction on DMRA: 0 purchases worth $0 and 1 sale worth $7K. Insiders have been net sellers over this period. The most recent filing was on Jul 6, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 6, 26 | Garrett WinslowGeneral Counsel | SELL | 245 | $29.98 | $7K |
Over the past 12 months, insiders at Damora Therapeutics, Inc. filed 0 open-market purchases worth $0 and 1 sale worth $7K on DMRA, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 6, 26.
1 different insider at Damora Therapeutics, Inc. filed open-market SEC Form 4 transactions on DMRA over the last 12 months.
InsiderTape plots every DMRA insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Damora Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →